Home /
Chemotherapy – University Hospital Vrije Universiteit
|
|
| Description: |
| Patients: This Phase II trial involved 41 patients with malignant pleural mesothelioma.
Treatment: The treatment consisted of a chemotherapy drug, oral etoposide (VP 16-213, vepesid). Toxicity: Grade 3-4 toxicities included hematological, nausea/vomiting, cutaneous reaction, and alopecia. Results: Median survival was 38 weeks (8.8 months). |
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."